Hospital Pharmacy

What Hospital Pharmacy does

Spitalpharmazie Thurgau AG is a privately held Swiss hospital pharmacy founded in 1951 and headquartered at Spitalcampus 1, Münsterlingen, in the canton of Thurgau. The company is organised into three operating divisions: pharmaceutical logistics supplying approximately 40 public and private hospitals, clinics, and care homes across Eastern Switzerland with a permanent assortment of around 2,500 products and average inventory of CHF 5 million; GMP-compliant in-house manufacturing (Eigenherstellung) of sterile and non-sterile medicines, including ready-to-use infusions and paediatric dosages that are not commercially available; and a central cytostatics laboratory (Zytostatiklabor) producing patient-individualised oncology infusions, syringes, and pumps for Kantonsspitäler Münsterlingen and Frauenfeld. Operations are supported by a specialised computer programme for chemotherapy standardisation, dose verification, and documentation, as well as cleanroom facilities with safety cabinets for cytotoxic handling.

The business is anchored by regulated, institutional activities: a Swissmedic wholesale distribution permit (Grosshandelsbewilligung), GMP-certified manufacturing, regional centre status for Tox Info Suisse, and membership in the Swiss anti-venom depot network, alongside a clinical pharmacy service line (drug information, compatibility and interaction reviews, dosing recommendations). Revenue is generated through transaction-based pharmaceutical wholesale supply, custom product manufacturing, and managed-service cytostatic preparation under contracts with cantonal hospitals, complemented by an institutional webshop. Its core customers are hospitals and care homes in the Thurgau canton and broader Ostschweiz, with the most significant relationship being the parent hospital group Spital Thurgau AG and its two Kantonsspitäler. The company employs 51-100 staff under Managing Director Volker Ebert, holds FPH-accredited training-centre status awarded in 2021, and operates with a small, regionally concentrated footprint rather than a scaling growth posture.

Name

Hospital Pharmacy

Legal name

Spitalpharmazie Thurgau AG

Website

https://sptag.ch

Company type

Private

Founded year

1951

Operating status

Operating

Headcount range

51–100 employees

Short description

Spitalpharmazie Thurgau AG is a Swissmedic-licensed hospital pharmacy in Münsterlingen, founded in 1951, supplying approximately 40 hospitals, clinics, and care homes across Eastern Switzerland with pharmaceutical logistics, GMP-certified custom manufacturing, patient-individualised cytostatic preparation, antidotes, and clinical pharmacy services.

Ownership category

akta.pro rank

Product category

Hospital Pharmacy Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Hospital & Health-System Pharmacies (Inpatient/Outpatient) (HLAFALAB)

akta.pro secondary industries

Full-Line Pharmaceutical Wholesalers (HLAIAJAA), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Hospital pharmacy services
• Pharmaceutical wholesale
• Chemotherapy manufacturing
• Sterile drug production
• Clinical pharmacy support

Headquarters

HQ city

Münsterlingen

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Wholesale Supply: Supply of finished medicinal products to hospitals, clinics and care homes in eastern Switzerland. The logistics division maintains a permanent assortment of approximately 2,500 pharmaceuticals with an average stock value of CHF 5 million. This constitutes the primary revenue stream, supported by a Swissmedic wholesale distribution permit.
2. Custom Pharmaceutical Manufacturing: Production of sterile and non-sterile hospital-relevant medicines not commercially available, including ready-to-use infusion solutions, paediatric dosages (capsules, suppositories), and other custom formulations. Revenue generated through product delivery to partner institutions.
3. Oncology/Cytostatic Therapy Preparation: Patient-individualised preparation of oncology therapies (infusions, syringes, pumps) for Kantonsspitäler Münsterlingen and Frauenfeld. Produced in a central cytotoxic laboratory with cleanrooms and safety cabinets. Revenue derived from healthcare service contracts with cantonal hospitals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Spitalpharmazie Thurgau AG provides pharmaceutical logistics, GMP-compliant manufacturing, and cytostatic/chemotherapy preparation services to approximately 40 hospitals, clinics, and care homes in Eastern Switzerland. The company maintains a permanent assortment of approximately 2,500 pharmaceuticals with an average inventory value of CHF 5 million, custom-manufactures hospital-relevant medicines not commercially available, prepares patient-individualized oncology therapies, and supplies antidotes and antivenoms on behalf of Tox Info Suisse.

Product overview

Spitalpharmazie Thurgau AG operates as a hospital pharmacy services company organized into three main divisions: Logistics, Production, and Cytostatics Manufacturing. The company provides pharmaceutical logistics to approximately 40 hospitals and care homes in Eastern Switzerland, manufactures hospital-relevant sterile and non-sterile medications under GMP standards, and produces patient-individualized oncology therapies. Core services include Antidota und Antivenine (antidotes and antivenoms), Logistik (pharmaceutical supply), Pharmazeutische Dienstleistungen (clinical pharmacy support), Eigenherstellung (custom drug manufacturing), and Zytostatiklabor (cytostatics compounding). Additional offerings include a Webshop for ordering and a weekly Pollenfluginformation service. The company has been in operation since 1951 and holds a Swissmedic wholesale authorization.

Differentiator

Problem solved

Functional benefit

Products and services

• Antidota und Antivenine (Antidotes and Antivenoms) Emergency antidotes and antivenoms for poisoning and snake or spider bites, maintained as a regional centre for Tox Info Suisse with stock held at Kantonsspital Münsterlingen and Kantonsspital Frauenfeld emergency locations.
• Logistik (Pharmaceutical Wholesale and Logistics) Pharmaceutical logistics service supplying approximately 40 public and private hospitals, clinics, and care homes in Eastern Switzerland with a permanent assortment of around 2,500 medications and an average inventory value of CHF 5 million, backed by a Swissmedic wholesale distribution permit.
• Pharmazeutische Dienstleistungen (Clinical Pharmacy Services) Clinical pharmacy services providing drug information, compatibility checks, interaction analysis, medication reviews, dosage recommendations, and therapeutic alternatives consultation to support optimized pharmacotherapy for hospital staff.
• Eigenherstellung (In-House Manufacturing) In-house manufacturing of hospital-relevant sterile and non-sterile medications not commercially available, including ready-to-use infusion solutions and pediatric dosages (capsules and suppositories), produced under international GMP standards with quality control and microbiology testing.
• Zytostatiklabor (Cytostatics Laboratory) Central cytostatics laboratory producing patient-individualized oncological therapies (infusions, syringes, pumps) for Kantonsspitäler Münsterlingen and Frauenfeld, using specialized cleanrooms and safety cabinets with computer-aided chemotherapy standardisation, dose verification, and documentation.
• Webshop (Online Ordering Platform) Online ordering platform for pharmaceutical products and supplies, accessible at webshop.stgag.ch/eshop for authorized partner institutions.

Quantifiable outcome

• ~40 hospitals, clinics and care homes served across Eastern Switzerland
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

15 partnerships are on record, tiered minor and core.

• Curaviva TG (curviva thurgau)minorOthersHealthcare sector association partner based in the canton of Thurgau. Collaboration focused on regional healthcare service enhancement and quality improvement for care homes and healthcare institutions.
• Gesundheitszentrum UnterengadinminorOthersRegional healthcare centre serving the Lower Engadine area. Partnership enables extended reach of pharmaceutical services to patients and institutions in this geography.
• Herz Neuro Zentrum BodenseeminorOthersHeart and neurology centre in the Lake Constance region. Collaboration to provide pharmaceutical services to cardiac and neurological patients at the Kreuzlingen clinic.
• Klinik SeeschauminorOthersClinic partner in the Thurgau/Lake Constance region receiving pharmaceutical supply and clinical services.
• Rehaklinik ZihlschlachtminorOthersRehabilitation clinic receiving pharmaceutical services. Partnership supports the clinic's medication supply and pharmaceutical care needs.
• Spitalverbund ARminorOthersHospital network in the canton of Appenzell Ausserrhoden. Collaboration to supply pharmaceutical products and services across the network.
• Venenklinik BellevueminorOthersSpecialist vein clinic receiving pharmaceutical supply and services as part of regional healthcare network.
• FlurystiftungminorOthersFlury Foundation hospital foundation. Partnership for healthcare delivery within the foundation's hospital network.
• Spital MännedorfminorOthersHospital in Männedorf receiving pharmaceutical supply and services as a regional partner.
• Spital Thurgau AGcoreOthersThe parent hospital group. Spitalpharmazie Thurgau AG is a subsidiary serving both Kantonsspitäler Münsterlingen and Frauenfeld. This is the core and most significant institutional relationship, providing supply, manufacturing, chemotherapy preparation and pharmaceutical services.
• Radiologie Nordost (RNO-Zentren)minorOthersDiagnostic radiology centre network in northeastern Switzerland. Partnership for radiology-related pharmaceutical supply and services.
• Spital UsterminorOthersHospital in Uster receiving pharmaceutical supply as a regional partner institution.
• Tox Info SuissecoreStrategic or Co-development PartnerSpitalpharmazie Thurgau AG serves as a regional centre of Tox Info Suisse for antidotes. The company coordinates and stocks antidotes for poisoning emergencies at Kantonsspital Münsterlingen (emergency station) and Kantonsspital Frauenfeld (emergency pharmacy).
• Swiss Antivenom Depot Network (Netzwerk der schweizerischen Antivenin-Depots)coreStrategic or Co-development PartnerThe company is a member of the Swiss Anti-venom Depot Network, which coordinates snake and spider venom serum stocks across Switzerland. Spitalpharmazie Thurgau maintains anti-venom inventory for the region.
• SwissmediccoreOthersSwiss drug regulatory authority. Spitalpharmazie Thurgau AG holds a Swissmedic wholesale distribution permit for medicines and controlled substances, reports batch recalls, processes safety-related drug information (DHPC), and manages adverse event reporting through the electronic vigilance portal.

Scale indicators4 records

Recent moves7 records

Expansion highlights3 records

Direct peers

• Spitalapotheke Kantonsspital Basel-Stadt: University Hospital Basel hospital pharmacy performing GMP manufacturing and patient-individualized cytostatic preparation for major Swiss teaching hospitals — comparable in regulatory positioning, scope of services and institutional customer base.
• Spitalapotheke Inselspital Bern: Hospital pharmacy at the Bern University Hospital offering GMP-certified manufacturing, cytostatic compounding and clinical pharmacy services across a multi-site cantonal hospital network — same operating model as Spitalpharmazie Thurgau at a larger scale.
• Spitalapotheke Universitätsspital Zürich: Hospital pharmacy at Switzerland's largest university hospital; provides GMP manufacturing, sterile/cytotoxic compounding and clinical pharmacy services to a large hospital network — directly comparable service mix and regulatory framework to Spitalpharmazie Thurgau.
• Bichsel AG: Swiss pharmaceutical company specializing in sterile manufacturing, infusion solutions and hospital-relevant preparations; close functional peer to Spitalpharmazie's Eigenherstellung division for small-batch sterile medicines.
• Spitalapotheke Luzerner Kantonsspital (LUKS): Hospital pharmacy serving the Lucerne cantonal hospital group with sterile manufacturing, cytotoxic compounding and clinical pharmacy services — same Swissmedic-licensed operating model across multiple cantonal sites.

Broad incumbents

• Ofac: Cooperative pharmaceutical wholesaler owned by Swiss pharmacists, distributing drugs and pharmacy sundries to member pharmacies and care homes; competes with Spitalpharmazie on retail-side pharmaceutical supply.
• Galexis AG: Switzerland's leading national pharmaceutical wholesaler (Galenica Group) supplying pharmacies and hospitals nationwide; competes with Spitalpharmazie's logistics stream at much greater scale and SKU breadth.
• Hänseler AG: Swiss pharmaceutical wholesaler and manufacturer serving pharmacies, hospitals and industry with a broad product portfolio and own manufacturing capabilities — directly comparable GMP manufacturing plus distribution combination at national scale.
• Gebro Pharma AG: Swiss pharmaceutical manufacturer and wholesaler with GMP-certified production and distribution; comparable GMP manufacturing footprint serving Swiss institutional customers, though with a broader branded-generic portfolio.

Regional players

• Dr. E. Gräub AG: Swiss veterinary and specialty pharmaceutical manufacturer/distributor; a smaller-scale regional GMP manufacturer that illustrates the pool of potential Swiss specialty pharma partners/competitors adjacent to Spitalpharmazie's niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/spitalpharmazie-thurgau-ag

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospital Pharmacy